Preexposure prophylaxis approved for COVID-19; Nexletol and Nexlizet gain expanded approval; Novel Duchenne muscular dystrophy treatment; First blood test to screen for malaria in donors; Warning letter for OTC topical analgesic products.

Category Product/Brand Eye Cream for Wrinkles La Roche-Posay Face Moisturizers CeraVe Face Washes and Cleansers CeraVe Night Creams CeraVe Retinol Creams and Serums Neutrogena Sunscreen for Face EltaMD Vitamin C Serum La Roche-Posay Vitamins for Hair Growth Nutrafol Wrinkle Creams Neutrogena

Category Product/Brand Children’s Cough Medicines Children’s Delsym Cough Drops Halls Cough Suppressants Delsym Diarrhea Medicines and Treatments Imodium Eye Vitamins Bausch + Lomb Ocuvite Fish Oil/Omega-3 Supplements Nature Made Laxatives MiraLAX Multivitamins for Men Centrum Multivitamins for Women One A Day Nausea Remedies Dramamine Nausea

Participants were asked to rank products in 132 OTC categories.

Xolair is an anti-immunoglobulin E antibody, for the treatment of IgE-mediated food allergies in patients aged 1 year and older for the reduction of type 1 allergic reactions, including anaphylaxis, that may occur with accidental exposure to 1 or more foods.

Nasal spray approved for chronic rhinosinusitis; Endothelin receptor antagonist gains approval to lower blood pressure in hypertension; One-time stem cell treatment approved for metachromatic leukodystrophy; NASH treatment gains accelerated approval; New automated insulin delivery system for type 1 diabetes.

The clearance rate of high-risk HPV16 and/or HPV18 was 31.4% vs 15.4% for the APL-1702 and placebo group, respectively.